Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.52 |
| ▸ | CALML3 | P27482 | 6/20 | 0.49 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.49 |
| ▸ | SDHA | P31040 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14432644 | 0.87 | MAOA (0.58) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL1393183 | 0.82 | MAOA (0.53) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL16306712 | 0.81 | MAOA (0.54) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL1393880 | 0.80 | MAOA (0.53) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL1393882 | 0.80 | MAOA (0.53) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL13180591 | 0.80 | MAOA (0.64) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL14026448 | 0.80 | MAOA (0.57) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL1394259 | 0.80 | MAOA (0.57) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL7938091 | 0.79 | MAOA (0.65) | MAOACALML3MAOBPTGS1SDHA | |
| SCHEMBL17747988 | 0.79 | MAOA (0.69) | MAOACALML3MAOBPTGS1SDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2492264-A2 | Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same | Rib-X Pharmaceuticals, Inc. (US) | 2012-08-29 | — | — | EP | disclosed |